Endosc Int Open 2015; 03(01): E63-E68
DOI: 10.1055/s-0034-1390889
Original article
© Georg Thieme Verlag KG Stuttgart · New York

25-gauge histology needle versus 22-gauge cytology needle in endoscopic ultrasonography-guided sampling of pancreatic lesions and lymphadenopathy

Georgios Mavrogenis
1   Department of Gastroenterology, Grand Hôpital de Charleroi, Charleroi, Belgium
2   Department of Hepato-gastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
,
Birgit Weynand
3   Department of Pathology, Centre Hospitalier Universitaire Dinant Godinne, Université Catholique de Louvain, Yvoir, Belgium
,
Alain Sibille
1   Department of Gastroenterology, Grand Hôpital de Charleroi, Charleroi, Belgium
,
Hocine Hassaini
1   Department of Gastroenterology, Grand Hôpital de Charleroi, Charleroi, Belgium
,
Pierre Deprez
2   Department of Hepato-gastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
,
Cédric Gillain
1   Department of Gastroenterology, Grand Hôpital de Charleroi, Charleroi, Belgium
,
Philippe Warzée
1   Department of Gastroenterology, Grand Hôpital de Charleroi, Charleroi, Belgium
› Author Affiliations
Further Information

Publication History

submitted 13 June 2014

accepted after revision 26 August 2014

Publication Date:
12 December 2014 (online)

Background and study aims: A new 25-gauge (G) endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) device (EchoTip ProCore; Cook Medical, Bloomington, Indiana, USA) has been developed, which features a hollowed-out reverse bevel to trap core samples. However, data on the differences between the diagnostic yield of the 25G EchoTip ProCore and that of a 22G standard needle are limited.

Patients and methods: This pilot study included 27 patients referred during an 11-month period for EUS-FNA of pancreatic masses and enlarged lymph nodes adjacent to the upper gastrointestinal tract. Each lesion was punctured once by both a 25G EchoTip ProCore needle and a 22G standard needle (EchoTip; Cook Medical) with capillary sampling. Blinded histocytologic analyses were conducted. The final diagnosis was based on FNA findings of malignant cells, pathologic analysis of the surgical specimen, and/or radiologic and clinical follow-up of at least 7 months.

Results: A total of 28 EUS-FNA procedures targeting masses of the pancreas (n = 19) and lymph nodes (n = 9) were performed. No complications were encountered. Single-pass sensitivity rates for pancreatic and lymph node malignancy were equal for the needle types: 89.5 % (95 %CI 66.82 – 98.39) and 66 % (95 %CI 24.1 – 94), respectively. There were no significant differences between the needles in terms of EUS visualization (P = 0.125), amount of blood contamination (P = 0.705), macroscopic quantity of the material (P = 0.858), quality of the cytology (P = 0.438), and adequacy and accuracy of the cell block material (P = 0.220).

Conclusions: Both needles were safe and successful in terms of a high diagnostic yield, with similar histocytologic results.

The results of this study were presented at Digestive Disease Week (DDW) 2014, Chicago, Illinois.

This trial was registered at ClinicalTrials.gov (B027201316271).

 
  • References

  • 1 Wiersema MJ, Vilmann P, Giovannini M et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997; 112: 1087-1095
  • 2 Gress FG, Hawes RH, Savides TJ et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy using linear array and radial scanning endosonography. Gastrointest Endosc 1997; 45: 243-250
  • 3 Gress F, Gottlieb K, Sherman S et al. Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med 2001; 134: 459-464
  • 4 Iglesias-Garcia J, Poley JW, Larghi A et al. Feasibility and yield of a new EUS histology needle: results from a multicenter, pooled, cohort study. Gastrointest Endosc 2011; 73: 1189-1196
  • 5 Giovannini M, Monges GM, Iglesias-Garcia J et al. Prospective multicenter evaluation of a novel 22-G Echo-Tip Procore histology EUS-needle in patients with a solid pancreatic mass [abstract 796]. Gastrointest Endosc 2011; 73 : AB152-AB153
  • 6 Iwashita T, Nakai Y, Samarasena JB et al. High single-pass diagnostic yield of a new 25-gauge core biopsy needle for EUS-guided FNA biopsy in solid pancreatic lesions. Gastrointest Endosc 2013; 77: 909-915
  • 7 Bang JY, Hebert-Magee S, Trevino J et al. Randomized trial comparing the 22-gauge aspiration and 22-gauge biopsy needles for EUS-guided sampling of solid pancreatic mass lesions. Gastrointest Endosc 2012; 76: 321-327
  • 8 Witt BL, Adler DG, Hilden K et al. A comparative needle study: EUS-FNA procedures using the HD ProCore™ and EchoTip® 22-gauge needle types. Diagn Cytopathol 2013; 41: 1069-1074
  • 9 Strand DS, Jeffus SK, Sauer BG et al. EUS-guided 22-gauge fine-needle aspiration versus core biopsy needle in the evaluation of solid pancreatic neoplasms. Diagn Cytopathol 2014; 42: 751-758
  • 10 Madhoun MF, Wani SB, Rastogi A et al. The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis. Endoscopy 2013; 45: 86-92
  • 11 Imazu H, Uchiyama Y, Kakutani H et al. A prospective comparison of EUS-guided FNA using 25-gauge and 22-gauge needles. Gastroenterol Res Pract 2009; 2009: 546390
  • 12 Lee JK, Choi JH, Lee KH et al. A prospective, comparative trial to optimize sampling techniques in EUS-guided FNA of solid pancreatic masses. Gastrointest Endosc 2013; 77: 745-751
  • 13 Levy MJ, Wiersema MJ. EUS-guided Trucut biopsy. Gastrointest Endosc 2005; 62: 417-426
  • 14 Vilmann P, Săftoiu A, Hollerbach S et al. Multicenter randomized controlled trial comparing the performance of 22 gauge versus 25 gauge EUS-FNA needles in solid masses. Scand J Gastroenterol 2013; 48: 877-883